XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect of Accounting Change [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Cumulative Effect of Accounting Change [Member]
Accumulated Other Comprehensive Gain (Loss) [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect of Accounting Change [Member]
Balance at Dec. 31, 2020 $ 761,759 $ (96,792) $ 8 $ 3,609,877 $ (156,953) $ 3 $ (2,848,129) $ 60,161
Balance (in shares) at Dec. 31, 2020     79,374          
Exercise of options for common stock 12,963     12,963        
Exercise of options for common stock, shares     283          
Vest of restricted stock units/awards     277          
Shares withheld for taxes (1,432)     (1,432)        
Shares withheld for taxes, shares     (18)          
Issuance of common stock for cash, net of offering costs 548,532   $ 1 548,531        
Issuance of common stock for cash, net of offering costs, shares     7,099          
Issuance of common stock under employee stock purchase plan 7,839     7,839        
Issuance of common stock under employee stock purchase plan, shares     112          
Stock-based compensation 113,943     113,943        
Purchase of capped call share options for 2027 Notes 0              
Partial settlement of capped call share options for 2024 Notes 0              
Unrealized losses from available-for-sale securities, net of tax (23)         (23)    
Net loss (418,780)           (418,780)  
Balance at Dec. 31, 2021 928,009   $ 9 4,134,768   (20) (3,206,748)  
Balance (in shares) at Dec. 31, 2021     87,127          
Exercise of options for common stock 22,573     22,573        
Exercise of options for common stock, shares     318          
Vest of restricted stock units/awards     389          
Issuance of common stock under employee stock purchase plan 7,470     7,470        
Issuance of common stock under employee stock purchase plan, shares     116          
Stock-based compensation 233,018     233,018        
Purchase of capped call share options for 2027 Notes (127,305)     (127,305)        
Partial settlement of capped call share options for 2024 Notes 26,317     26,317        
Unrealized losses from available-for-sale securities, net of tax (1,644)         (1,644)    
Net loss (703,488)           (703,488)  
Balance at Dec. 31, 2022 384,950   $ 9 4,296,841   (1,664) (3,910,236)  
Balance (in shares) at Dec. 31, 2022     87,950          
Exercise of options for common stock $ 40,485     40,485        
Exercise of options for common stock, shares 528,909   528          
Vest of restricted stock units/awards     645          
Issuance of common stock for exchange of 2024 Notes, shares     4,456          
Issuance of common stock for exchange of 2024 Notes, value $ 693,377     693,377        
Issuance of common stock under employee stock purchase plan 10,761     10,761        
Issuance of common stock under employee stock purchase plan, shares     153          
Stock-based compensation 182,514     182,514        
Purchase of capped call share options for 2027 Notes 0              
Partial settlement of capped call share options for 2024 Notes 80,645     80,645        
Unrealized losses from available-for-sale securities, net of tax 2,582         2,582    
Net loss (535,977)           (535,977)  
Balance at Dec. 31, 2023 $ 859,337   $ 9 $ 5,304,623   $ 918 $ (4,446,213)  
Balance (in shares) at Dec. 31, 2023     93,732